CD8A and cancer: For instance, CD8+ T cells are a major effector cell type in anti‐cancer immunity (He et al. 2019), and γδ T cells exhibit strong cytotoxicity and pro‐inflammatory activity, enabling them to eliminate a wide range of tumor cells.